Book contents
- Club Drugs and Novel Psychoactive Substances
- Club Drugs and Novel Psychoactive Substances
- Copyright page
- Contents
- Acknowledgements
- Part I Introduction
- Part II Stimulant Drugs
- Chapter 6 Stimulant Drugs: Introduction
- Chapter 7 Stimulant Drugs: Cocaine
- Chapter 8 Stimulant Drugs: Amphetamine-Type Stimulants
- Chapter 9 Stimulant Drugs: Methamphetamine
- Chapter 10 Stimulant Drugs: MDMA and Drugs with Similar Effects
- Chapter 11 Stimulant Drugs: Synthetic Cathinones
- Part III Depressant Drugs
- Part IV Synthetic Cannabinoid Receptor Agonists
- Part V Hallucinogens
- References
- Index
Chapter 6 - Stimulant Drugs: Introduction
from Part II - Stimulant Drugs
Published online by Cambridge University Press: 21 September 2020
- Club Drugs and Novel Psychoactive Substances
- Club Drugs and Novel Psychoactive Substances
- Copyright page
- Contents
- Acknowledgements
- Part I Introduction
- Part II Stimulant Drugs
- Chapter 6 Stimulant Drugs: Introduction
- Chapter 7 Stimulant Drugs: Cocaine
- Chapter 8 Stimulant Drugs: Amphetamine-Type Stimulants
- Chapter 9 Stimulant Drugs: Methamphetamine
- Chapter 10 Stimulant Drugs: MDMA and Drugs with Similar Effects
- Chapter 11 Stimulant Drugs: Synthetic Cathinones
- Part III Depressant Drugs
- Part IV Synthetic Cannabinoid Receptor Agonists
- Part V Hallucinogens
- References
- Index
Summary
Stimulant drugs belong to a variety of different chemical groups. They stimulate the central nervous system by increasing the availability of key neurotransmitters at brain receptor sites, particularly dopamine, noradrenaline and serotonin. Stimulant drugs increase the levels of active neurotransmitters by increasing their release from pre-synaptic neurons or by inhibiting the reuptake of these neurotransmitters. Some stimulants do both.
- Type
- Chapter
- Information
- Club Drugs and Novel Psychoactive SubstancesThe Clinician's Handbook, pp. 23 - 30Publisher: Cambridge University PressPrint publication year: 2020